• BIVDA members area

BIVDA Press Releases

European Parliament endorses new Regulation on In Vitro Diagnostics

The European Parliament has endorsed the new Regulation on In Vitro Diagnostics (IVDR), a development welcomed by the British In Vitro Diagnostics Association (BIVDA). 

Read More »

PwC analysis highlights economic footprint of UK Life Sciences

PwC analysis highlights economic footprint of UK Life Sciences

The productivity of the UK’s Life Sciences sector is more than double the UK average, says a new report launched today [6 March].

​​​The PwC report, 'The Economic contribution of the UK Life Sciences industry​', commissioned by the Association of the British Pharmaceutical Industry (ABPI) and supported by the Association of the British Healthcare Industry (ABHI), the BioIndustry Association (BIA), and the British In Vitro Diagnostics Association (BIVDA), shows that the average productivity of UK Life Sciences employees, expressed as Gross Value Added (GVA), is £104,000 compared to the UK GVA average of £49,000.

Other key findings include:

Read More »

Autumn Statement 2016: BIVDA’s Response

Commenting on the 2016 Autumn Statement, BIVDA’s Chief Executive Doris-Ann Williams MBE said:

“As the UK looks to establish its new place in the world following the outcome of the EU Referendum, we welcome...

Read More »

BIVDA Response to Cancer Research UK Report on Pathology Services

Cancer Research UK have today (23 November 2016) published a report which finds that UK pathology services are struggling to meet the rising number of patient samples that need to be tested. 

Read More »

BIVDA responds to the final report of the Accelerated Access Review

Doris-Ann Williams MBE, Chief Executive of BIVDA, has responded to the publication of the final report of the Accelerated Access Review. More information about the review can be found here.

Read More »

BIVDA Attends UN Meeting on Antimicrobial Resistance

Doris-Ann Williams MBE, Chief Executive of the British In Vitro Diagnostics Association (BIVDA), represented the IVD industry at the United Nations General Assembly meeting on antimicrobial resistance (AMR) on Wednesday (22 September 2016).

Read More »

BIVDA, ABPI and CRUK release briefing on new arrangements for commissioning and funding of six molecular diagnostic tests for cancer

BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commissioning and funding of six molecular diagnostic tests for cancer in the NHS in England for 2016/17. 

Read More »

Pages: Previous1234NextReturn Top